Jacek Antas
Fortune : 683 002 $ au 31/07/2026
Fortune : 683 002 $ au 31/07/2026
Jacek Antas is currently Chairman at Helix BioPharma Corp.
Formerly, Mr. Antas was Chief Executive Officer at Antas Srl.
Education includes a graduate degree from Warsaw School of Economics.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HELIX BIOPHARMA CORP. 0,84 % | 15/12/2025 | 638 320 ( 0,84 % ) | 683 002 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HELIX BIOPHARMA CORP. | Président | 18/04/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Antas Srl
Antas Srl Engineering & ConstructionIndustrial Services Provides integrated installation, maintenance, operation and fuel management services of heating systems | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Warsaw School of Economics
Warsaw School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antas Srl
Antas Srl Engineering & ConstructionIndustrial Services Provides integrated installation, maintenance, operation and fuel management services of heating systems | Industrial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national